• October 8, 2020  

    NCCN Guidelines for Patients: Liver Cancer Bookmark

    George Lundberg, MD

    PDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes: 

    The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about Liver Cancer.

    .

    Go to full document published by the NCCN.

  • August 18, 2020  

    Tumor Boards—What Are They and How Can They Help You?

    Julie Friedland, PhD

    One of the most powerful tools in cancer treatment today is the tumor board—a group of cancer experts who delve into individual cancer patients’ cases to help them explore their treatment options. As our world increasingly shifts online, virtual tumor boards enable many more patients to benefit from leading experts’ insights. Understanding how tumor boards work could help you get the most out of… Read more »

  • August 15, 2020  

    New Focus on ADT in Prostate Cancer Guideline Bookmark

    George Lundberg, MD

    Article from MedPage Today curated by Editor in Chief George Lundberg, MD, who notes: 

    Hormone therapy has been a mainstay in the treatment of metastatic prostate cancer. But, until now, guidelines have been short on detail. This news story outlines 38 approved additions to guidelines.

    Go to full article published by MedPage Today.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • August 14, 2020  

    Global Post-Marketing Safety Surveillance of Tumor Treating Fields (TTFields) in Patients With High-Grade Glioma in Clinical Practice Bookmark

    George Lundberg, MD

    Research paper from the Journal of Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes: 

    Safety and potential adverse effects are serious issues with many cancer treatments. This academic paper outlines post-marketing research that reveals few adverse effects from a type of treatment known as tumor-treating fields (TTF) in brain malignancies.

    Go to full paper published in the Journal of Neuro-Oncology.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • June 30, 2020  

    Helping Cancer Patients Access their Own Health Data

    With: Deven McGraw

    For many cancer patients, the ability to access one’s own medical records can aid their treatment decisions, or allow them to donate their personal data for research that could help other patients. But these records can be difficult to obtain and sort through. Here, our Curious Dr. George asks Deven McGraw, Chief Regulatory Officer at Ciitizen, how her company helps patients access and organize… Read more »

  • May 12, 2020  

    Pancreatic Cancer Survival Rates: What Do They Really Mean?

    Lola Rahib, PhD

    The American Cancer Society estimates that in 2020, 57,600 people in the U.S. will be diagnosed with pancreatic cancer and 47,050 will die from the disease. But not everyone’s pancreatic cancer is the same. Understanding what survival rates mean—and which factors can impact them—could help you navigate your or your loved one’s disease. What is the five-year relative survival rate for pancreatic cancer? In… Read more »

  • February 22, 2020  

    Accelerating Children’s Access to New Treatments for High Risk Brain Tumors Bookmark

    George Lundberg, MD

    Article from Michigan Health Lab curated by Editor in Chief George Lundberg, MD, who notes: 

    Children with serious brain tumors need access to as many clinical trials as possible. This new consortium will encourage that.

    Go to full article published by Michigan Health Lab.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • February 11, 2020  

    Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline Bookmark

    George Lundberg, MD

    Research paper from the Journal of Clinical Oncology curated by Editor in Chief George Lundberg, MD, who notes: 

    There has been confusion about how to conduct follow-up for a patient with lung cancer who has received therapy intended to cure. This new guideline intends to clarify best practice.

    Go to full paper published in the Journal of Clinical Oncology.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • December 13, 2019  

    Esophageal Cancer Treatment (Adult) (PDQ®)–Patient Version Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    Esophageal cancer is common and difficult to treat; causation, classification and diagnosis are evolving. Read here a patient-friendly overview of the disease from the U.S. National Cancer Institute.

    .

  • December 13, 2019  

    Cervical Cancer – Overview Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    The third leading cause of cancer death of women in developing countries, advanced cervical cancer is relatively rare in the U.S. This comprehensive review summarizes it nicely.

    .